21-Aug-2026
No headlines found.
CorVel Announces Revenues and Earnings
Globe Newswire (Wed, 5-Aug 6:13 AM ET)
CorVel Corporation to Host Live Earnings Release Webcast
Globe Newswire (Mon, 27-Jul 6:23 AM ET)
Globe Newswire (Wed, 8-Jul 7:14 AM ET)
CorVel Launches Marketwise Repricing to Deliver Smarter, Market-Based Medical Cost Containment
Globe Newswire (Wed, 17-Jun 7:12 AM ET)
CorVel Marks 35 Years on Nasdaq, Signals Next Phase of Long-Term Innovation and Growth
Globe Newswire (Tue, 2-Jun 7:07 AM ET)
CorVel Appoints Sarah Scott CEO and President; Michael G. Combs to Transition to Executive Chair
Globe Newswire (Mon, 1-Jun 4:30 PM ET)
CorVel Corp applies technology including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. It partners with employers, third-party administrators, insurance companies, and government agencies in managing worker's compensation and health, auto, and liability services. The company's solutions combine integrated technologies with a human touch providing services that include claims management, bill review, preferred provider networks, utilization management, case management, pharmacy services, directed care, and medicare services.
Corvel Corp. trades on the NASDAQ stock market under the symbol CRVL.
As of August 21, 2026, CRVL stock price declined to $70.15 with 108,247 million shares trading.
CRVL has a beta of 0.30, meaning it tends to be less sensitive to market movements. CRVL has a correlation of 0.01 to the broad based SPY ETF.
CRVL has a market cap of $3.54 billion. This is considered a Mid Cap stock.
In the last 3 years, CRVL traded as high as $128.61 and as low as $44.83.
The top ETF exchange traded funds that CRVL belongs to (by Net Assets): IJR, VTI, IWM, VB, VBK.
CRVL has underperformed the market in the last year with a return of -22.1%, while SPY returned +21.7%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in CRVL shares. However, CRVL has outperformed the market in the last 3 month and 2 week periods, returning +14.0% and +12.1%, while SPY returned +3.4% and -1.0%, respectively. This indicates CRVL has been having a stronger performance recently.
CRVL support price is $68.33 and resistance is $72.09 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CRVL shares will trade within this expected range on the day.